Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov 22;5(6):e936.
doi: 10.1002/hsr2.936. eCollection 2022 Nov.

The global, regional and national epidemiology, incidence, mortality, and burden of ovarian cancer

Afrooz Mazidimoradi  1 , Zohre Momenimovahed  2 , Leila Allahqoli  3 , Azita Tiznobaik  4 , Negar Hajinasab  5 , Hamid Salehiniya  6 , Ibrahim Alkatout  7
Affiliations

The global, regional and national epidemiology, incidence, mortality, and burden of ovarian cancer

Afrooz Mazidimoradi et al. Health Sci Rep. .

Abstract

Background: Ovarian cancer has the highest mortality rate among gynecological malignancies and is associated with poor prognosis. Since the accurate assessment of the global burden along with the trend of cancers contributes to the development of policies, this study aimed to explain the incidence, mortality, and burden of ovarian cancer using the global burden of disease (GBD) 2019 study.

Methods: Epidemiological data have been collected from the study of the GBD 2019. Data were extracted globally for 204 countries and groups based on a socio-demographic index (SDI), WHO regions, continents, World Bank regions, and 22 GBD regions.

Results: In 2019, a total of 294,422 new cases of ovarian cancer were reported. The highest age-standardized incidence rate (ASIR) was reported in areas with higher SDI, World high-income countries, continental Europe, and then America. In GBD regions, the highest age-standardized incidence is in Central Europe. In 2019, a total of 198,412 deaths due to ovarian cancer were reported. The highest ASR death is related to countries with high SDI and the World Bank high-income countries. In 2019, adjusted years of life with disabilities (DALYs) due to ovarian cancer were reported to be 5,359,737, of which 5,205,660 were related to lost years of life (YLLs), and 154,077 were related to years of life with disabilities (YLDs).

Conclusions: In 2019, the highest age-standardized incidence of ovarian cancer, ASR death, and DALYs ASR belong to the high SDI countries. Designing interventions based on risk factors as well as providing preventive approaches to reduce the risk of this cancer, improving the treatment of ovarian cancer, and using appropriate and invasive treatments are recommended.

Keywords: burden; global; incidence; mortality; ovarian cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Global crude rate of incidence, death, and disabilities (DALYs) of ovarian cancer (per 100.000) in 2019. [Color figure can be viewed at wileyonlinelibrary.com]
See this image and copyright information in PMC

References

    1. Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941‐1953. - PubMed
    1. Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H. Ovarian cancer in the world: epidemiology and risk factors. Int J Womens Health. 2019;11:287‐299. - PMC - PubMed
    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394‐424. - PubMed
    1. Zhou Z, Wang X, Ren X, Zhou L, Wang N, Kang H. Disease burden and attributable risk factors of ovarian cancer from 1990 to 2017: findings from the global burden of disease study 2017. Front Public Health. 2021;9:619581. - PMC - PubMed
    1. Badgwell D, Bast RC Jr. Early detection of ovarian cancer. Dis Markers. 2007;23(5‐6):397‐410. - PMC - PubMed

LinkOut - more resources